Anticancer activity of chamaejasmine: Effect on tubulin protein

Molecules

Volumn 16, Issue 8, 2011, Pages 6243-6254

  Fang, Wenlong ^a   Liu, Songtao ^b   Nie, Yingkun ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Hei Longjiang Disabled Federation for Human Care Clinic   (China)

Author keywords

Anti cancer activity; Chamaejasmine; Docking; PC 3 cells; Tubulin

Indexed keywords

ANTINEOPLASTIC AGENT; BIFLAVONOID; CHAMAEJASMIN; PACLITAXEL; TUBULIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL SURVIVAL; CERCOPITHECUS; CHEMICAL STRUCTURE; CHEMISTRY; DOG; DRUG EFFECT; FEMALE; HUMAN; IC 50; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN BINDING; THERMODYNAMICS; TUMOR CELL LINE; VERO CELL; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIFLAVONOIDS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DOGS; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, MOLECULAR; NEOPLASMS; PACLITAXEL; PROTEIN BINDING; THERMODYNAMICS; TUBULIN; VERO CELLS;

EID: 80052196057     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16086243     Document Type: Article

References (38)

1. Coxon, A.; Bush, T.; Saffran, D.; Kaufman, S.; Belmontes, B.; Rex, K.; Hughes, P.; Caenepeel, S.; Rottman, J.B.; Tasker, A.; et al. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors. Clin. Cancer Res. 2009, 15, 110-118.
2. Munroe, M.E.; Arbiser, J.L.; Bishop, G.A. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol. 2007, 179, 753-763.
3. Kavallaris, M.; Verrills, N.M.; Hill, B.T. Anticancer therapy with novel tubulin-interacting drugs. Drug Resist. Updat. 2001, 4, 392-401. (Pubitemid 34746873)
4. Shi, Q.; Chen, K.; Morris-Natschke, S.L.; Lee, K.H. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Curr. Pharm. Des. 1998, 4, 219-248. (Pubitemid 28277446)
5. Jordan, A.; Hadfield, J.A.; Lawrence, NJ.; McGown, A.T. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev. 1998, 18, 259-296. (Pubitemid 28346389)
6. Islam, M.N.; Iskander, M.N. Microtubulin binding sites as target for developing anticancer agents. Mini Rev. Med. Chem. 2004, 4, 1077-1104. (Pubitemid 39545451)
7. Jordan, M.A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat Rev. Cancer 2004, 4, 253-265. (Pubitemid 38525281)
8. Teicher, B.A. Newer cytotoxic agents: Attacking cancer broadly. Clin. Cancer Res. 2008, 14, 1610-1617. (Pubitemid 351469444)
9. Dumontet, C.; Sikic, B.I. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J. Clin. Oncol. 1999, 17, 1061-1070. (Pubitemid 29109340)
10. Chang, J.Y.; Yang, M.F.; Chang, C.Y.; Chen, C.M.; Kuo, C.C.; Liou, J.P. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. J. Med. Chem. 2006, 49, 6412-6415.
11. Chang, J.Y.; Hsieh, H.P.; Chang, C.Y.; Hsu, K.S.; Chiang, Y.F.; Chen, C.M.; Kuo, C.C.; Liou, J.P. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. J. Med. Chem. 2006, 49, 6656-6659.
12. Liou, J.P.; Wu, C.Y.; Hsieh, H.P.; Chang, C.Y.; Chen, C.M.; Kuo, C.C.; Chang, J.Y. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. J. Med. Chem. 2007, 50, 4548-4552.
13. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat Prod. 2003, 66, 1022-1037. (Pubitemid 36909859)
14. Cragg, G.M.; Newman, D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005, 100, 72-79. (Pubitemid 41073525)
15. Shi, Z.C. The Poisonous Plants in Chinese Pasture; China Agricultural Press: Beijing, China, 1997.
16. Zhao, S.H.; Wang, S.Q. Progress of Investigations and Application of Insecticide Plants; Guangdong Agricultural Sciences: Guangdong, China, 1997; pp. 26-28.
17. Feng, W.; Tetsuro, I.; Mitsuzi, Y. The antitumor activities of gnidimacrin isolated from Stellera chamaejasme L. Chin. J. Cancer Res. 1995, 17, 24-26.
18. Tang, X.; Hou, T. Development of chamaejasmin microemulsion and its biological activity against Aphis craccivora and Culex pipiens pallens. Flavour. Fragr. J. 2008, 23, 258-262.
19. Jing, Y.; Zhang, G.G.; Ma, E.L.; Zhang, H.M.; Guan, J.; He, J. Amentoflavone and the extracts from Selaginella tamariscina and their anticancer activity. Asian J. Traditional Med. 2010, 5, 226-229.
20. Downing, K.H. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu. Rev. Cell Dev. Biol. 2000, 16, 89-111. (Pubitemid 32037501)
21. Snyder, J.P.; Nettles, J.H.; Cornett, B.; Downing, K.H.; Nogales, E. The binding conformation of Taxol in beta-tubulin: A model based on electron crystallographic density. Proc. Natl. Acad. Sci. USA 2001, 98, 5312-5316. (Pubitemid 32397125)
22. Fu, Y.; Li, S.; Zu, Y.; Yang, G.; Yang, Z.; Luo, M.; Jiang, S.; Wink, M.; Efferth, T. Medicinal chemistry of paclitaxel and its analogues. Curr. Med. Chem. 2009, 16, 3966-3985.
23. Lowe, J.; Li, H.; Downing, K.H.; Nogales, E. Refined structure of alpha beta-tubulin at 3.5 A resolution. J. Mol. Biol. 2001, 313, 1045-1057. (Pubitemid 33081900)
24. InisghtII Version 2005, 2005 ed.; Accelrys Inc.: San Diego, CA, USA, 2005.
25. Robinson, M.W.; McFerran, N.; Trudgett, A.; Hoey, L.; Fairweather, I. A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. J. Mol. Graph. Model 2004, 23, 275-284. (Pubitemid 39463106)
26. Geney, R.; Sun, L.; Pera, P.; Bernacki, R.J.; Xia, S.; Horwitz, S.B.; Simmerling, C.L.; Ojima, I. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design. Chem. Biol. 2005, 12, 339-348. (Pubitemid 40406281)
27. Rodríguez-Menchaca, A.A.; Navarro-Polanco, R.A.; Ferrer-Villada, T.; Rupp, J.; Sachse, F.B.; Tristani-Firouzi, M.; Sánchez-Chapula, J.A. The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc. Natl. Acad. Sci. USA 2008, 105, 1364-1368. (Pubitemid 351397059)
28. Zhang, X.; Hu, Y.; Yuan, Z. Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity. Biochem. Biophys. Res. Commun. 2008, 370, 72-76.
29. Beccati, D. Investigations of Prebiotics and of Inter- and Intra-Molecular Glycan-Protein Interactions; G. Ronzoni' Institute for Chemical and Biochemical Research: Milan, Italy, 2009.
30. Yang, Z.W.; Yang, G.; Zu, Y.G.; Fu, Y.J.; Zhou, L.J. The conformational analysis and proton transfer of the neuraminidase inhibitors: A theoretical study. Phys. Chem. Chem. Phys. 2009, 11, 10035-10041.
31. Yang, Z.; Nie, Y.; Yang, G.; Zu, Y.; Fu, Y.; Zhou, L. Synergistic effects in the designs of neuraminidase ligands: Analysis from docking and molecular dynamics studies. J. Theor. Biol. 2010, 267, 363-374.
32. Wu, X.M.; Zu, Y.G.; Yang, Z.W.; Fu, Y.J.; Zhou, L.J.; Yang, G. Temperature-controlled molecular dynamics studies on the folding mechanism of the tubulin active peptides. Acta Phys. Chim. Sin. 2009, 4, 773-782.
33. Yang, G.; Wu, X.M.; Zu, Y.G.; Yang, Z.W.; Fu, Y.J.; Zhou, L.J. Molecular dynamic simulations on the folding and conformational insights of the truncated peptides. J. Theo. Comput. Chem. 2009, 8, 317-331.
34. Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.D.; Impey, R.W.; Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926-935.
35. Mitra, A.; Sept, D. Taxol allosterically alters the dynamics of the tubulin dimer and increases the flexibility of microtubules. Biophys. J. 2008, 95, 3252-3258.
36. Affinity User Guide; Accelrys Inc.: San Diego, CA, USA, 2005.
37. Adelman, S.A.; Doll, J.D. Generalized Langevin equation approach for atom/solid-surface scattering: General formulation for classical scattering off harmonic solids. J. Chem. Phys. 1976, 64, 2375-2388.
38. Mooberry, S.L.; Weiderhold, K.N.; Dakshanamurthy, S.; Hamel, E.; Banner, E.J.; Kharlamova, A.; Hempel, J.; Gupton, J.T.; Brown, M.L. Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrrole. Mol. Pharmacol. 2007, 72, 132-140. (Pubitemid 46998532)